ILK and neoplasm: Based on immunofluorescence analyses of ILK+ and CD11b+ (myeloid) cells in both tumours and adjacent normal tissues, elevated expression of ILK was apparent not only in tumour epithelium but also in the tumour-infiltrating myeloid (CD11b+) cells (Figure 7).